AVTX vs BEN · P/E 0.0, rev $441.0K vs P/E 36, rev $8.77B
Avalo Therapeutics Inc (AVTX) versus Franklin Resources Inc (BEN) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Franklin Resources Inc (BEN) is a asset management company listed on US.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Not investment advice. Open the AVTX and BEN stock pages for the full models.
Not investment advice.